WSJ
15 Jul 2026, 10:33 UTC · 2h ago
Johnson & Johnson Bumps Up Guidance as Sales Rise
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
15 Jul 2026, 10:33 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
The drug and medical-device maker raised its full-year forecast. — Upward revisions to annual guidance typically signal strong future earnings potential and drive stock price appreciation.
+0.60The company recorded higher sales in the second quarter. — Positive quarterly sales growth confirms current demand and provides the fundamental basis for the raised guidance.
+0.40Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Continue reading
6 related stories
Top 3 movers · tap to explore
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Barrons
1h ago
